PCM
GILD icon

Polaris Capital Management’s Gilead Sciences GILD Stock Holding History

Polaris Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4M Sell
153,300
-98,900
-39% -$13M 1.82% 20
2026
Q1 		$35.1M Sell
252,200
-12,900
-5% -$1.81M 2.88% 11
2025
Q4 		$32.5M Sell
265,100
-47,300
-15% -$5.75M 2.7% 12
2025
Q3 		$34.7M Sell
312,400
-12,500
-4% -$1.42M 2.28% 18
2025
Q2 		$36M Sell
324,900
-34,800
-10% -$3.7M 2.4% 11
2025
Q1 		$40.3M Sell
359,700
-57,900
-14% -$5.97M 2.3% 10
2024
Q4 		$38.6M Sell
417,600
-10,700
-2% -$963K 1.86% 20
2024
Q3 		$35.9M Buy
428,300
+6,400
+2% +$488K 1.77% 24
2024
Q2 		$28.9M Buy
421,900
+28,700
+7% +$1.92M 1.55% 33
2024
Q1 		$28.8M Sell
393,200
-42,500
-10% -$3.27M 1.44% 36
2023
Q4 		$35.3M Sell
435,700
-11,100
-2% -$864K 1.7% 32
2023
Q3 		$33.5M Sell
446,800
-194,700
-30% -$15M 1.8% 26
2023
Q2 		$49.4M Sell
641,500
-19,600
-3% -$1.56M 1.86% 26
2023
Q1 		$54.9M Sell
661,100
-300
-0% -$24.8K 2.05% 14
2022
Q4 		$56.8M Buy
661,400
+9,600
+1% +$760K 1.98% 17
2022
Q3 		$40.2M Buy
+651,800
New +$41.1M 1.58% 28

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Polaris Capital Management's GILD Position: Q2 2026 in Review

Polaris Capital Management reduced its Gilead Sciences (GILD) stake by 39% in Q2 2026, selling an estimated $13M and leaving 153,300 shares worth $19.4M. The position accounts for 1.82% of the portfolio, ranked #20.

Polaris Capital Management first reported a position in GILD in Q3 2022 and has held it in 16 quarters since. The position peaked at $56.8M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Polaris Capital Management held 153,300 shares of Gilead Sciences worth $19.4M as of Q2 2026.
  • Polaris Capital Management sold 98,900 Gilead Sciences shares in Q2 2026, an estimated $13M.
  • Gilead Sciences made up 1.82% of Polaris Capital Management's portfolio in Q2 2026, its #20 holding.
  • Polaris Capital Management first reported a position in Gilead Sciences in Q3 2022 and has held it in 16 quarters since.
  • Polaris Capital Management's Gilead Sciences position peaked at $56.8M in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Polaris Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.